PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.81
ESG score 90-95% of SAVA's 63.11. Bill Ackman would demand clear ESG improvement catalysts.
54.80
Environmental score 80-90% of SAVA's 63.13. Walter Schloss would scrutinize carbon exposure and transition planning.
57.90
Social score 90-95% of SAVA's 61.04. Bill Ackman would demand clear social improvement catalysts.
60.72
Governance score 90-95% of SAVA's 65.15. Bill Ackman would demand clear governance improvement catalysts.